ASX:CU6 (Australia)  
Clarity Pharmaceuticals Ltd logo

Clarity Pharmaceuticals Ltd

A$ 0.91 (-4.21%) Dec 9
P/E:
At Loss
P/B:
2.58
Market Cap:
A$ 235.93M ($ 160.31M)
Enterprise V:
A$ 143.59M ($ 97.57M)
Volume:
177.56K
Avg Vol (2M):
109.00K
Volume:
177.56K
Market Cap A$:
235.93M
Market Cap $:
160.31M
PE Ratio:
At Loss
Avg Vol (2-Month):
109.00K
Enterprise Value A$:
143.59M
Enterprise Value $:
97.57M
PB Ratio:
2.58

Business Description

Description
Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.92
Interest Coverage No Debt
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 25.22
9-Day RSI 40.91
14-Day RSI 49.75
6-1 Month Momentum % 117.39
12-1 Month Momentum % 35.14

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 13.26
Quick Ratio 13.26
Cash Ratio 12.3

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
ROE % -24.57
ROA % -23.34
ROIC % -993.35
ROC (Joel Greenblatt) % -1265.82
ROCE % -31.31